CDMO Samsung Biologics Highlights Climate Actions, Job Creation, and Corporate Social Responsibility in 2022 ESG Report
Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has released its second annual environmental, social, and governance(ESG) report. Addressing climate change is a central focus of the communiqué, which details the CDMO’s emissions reduction goals and involve